Evidence map›Paper›PMID 41279946›Full record

ArticlebioRxiv : the preprint server for biology2025

Macrodomain ADP-ribose binding but not ADP-ribosylhydrolase activity is critical for chikungunya virus infection of

Eugenia S Bardossy, Lena Bergmann, Annabelle Henrion-Lacritick, Jared Nigg, Galen J Correy, Alan Ashworth, James S Fraser, Maria-Carla Saleh

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Eugenia S BardossyViruses and RNAi Unit, Institut Pasteur, Université Paris Cité, F-75015 Paris, France.ORCID 0000-0003-3255-0923
Lena BergmannDepartment of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA 94158.
Annabelle Henrion-LacritickViruses and RNAi Unit, Institut Pasteur, Université Paris Cité, F-75015 Paris, France.
Jared NiggViruses and RNAi Unit, Institut Pasteur, Université Paris Cité, F-75015 Paris, France.
Galen J CorreyDepartment of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA 94158.
Alan AshworthHelen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA.
James S FraserDepartment of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA 94158.ORCID 0000-0002-5080-2859
Maria-Carla SalehViruses and RNAi Unit, Institut Pasteur, Université Paris Cité, F-75015 Paris, France.

Funding

Targeting Viroporins and Coronavirus M ProteinU19AI171110 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Nevan J Krogan · 2022 to 2026
$103.4M
NIAID NIH HHS U19 AI171110
6 · The paper itself

Abstract

Viral macrodomains are promising antiviral targets that counteract host ADP-ribosylation-mediated antiviral responses in mammals. However, their role in dual-host viruses within the mosquito vector is largely unknown. Here, we investigated the role of the chikungunya virus (CHIKV) macrodomain by mutating the active site asparagine 24 (N24). In both mammalian and mosquito cell lines, these enzymes rapidly acquired compensatory mutations at aspartate 31 (D31). We show that while N24 mutations abolish ADP-ribosylhydrolase catalytic activity and reduce folding stability, ADP-ribose binding remains intact. Furthermore, the D31 compensatory mutations do not markedly rescue catalytic activity or folding stability. Structures of the compensatory mutant macrodomains suggest the importance of ADP-ribose binding, rather than ADP-ribosylhydrolase catalysis as the selective pressure driving their accumulation. In mammalian cells, viral mutants bearing the catalytic and compensatory mutations replicated less efficiently than wild-type virus in interferon-competent cell lines. However, their replication remained unaffected in mosquito cells. In

Identifiers

PMID41279946
PMCPMC12632316

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.